🇺🇸 FDA
Patent

US 8344013

Dual-acting imidazole antihypertensive agents

granted A61KA61K31/415A61K31/4164

Quick answer

US patent 8344013 (Dual-acting imidazole antihypertensive agents) held by Theravance, Inc. expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/415, A61K31/4164, A61K31/417, A61K31/4188